Murchinson’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Murchinson’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-120,049	Closed	-$15.8M	–	120
2025 Q1	$15.8M	Buy	+120,049	New	+$15M	0.84%	13

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Murchinson's ITCI Position: Q2 2025 in Review

Murchinson sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 120,049 shares — an estimated $15.8M sold.

Murchinson first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $15.8M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Murchinson reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Murchinson sold 120,049 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $15.8M.
Murchinson first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Murchinson's Intra-Cellular Therapies Inc. position peaked at $15.8M in Q1 2025.
3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Murchinson's 13F filing for Q2 2025, filed 14 Aug 2025.